Enter your keyword

Mini Brain


Commercializing organoids

Organome is creating a commercial platform that will offer functional organ equivalents, or organoids, for research applications, more specifically for drug screening and disease modeling.

The Company’s initial product is the miniature brain organoid, or Mini Brain, which is designed to serve as a human-relevant 3D model in preclinical research, during drug discovery by the pharmaceutical industry as well as a model for (developmental) neurotoxicity testing by the chemicals industry.

Classic animal-based models provide poor levels of predictability for human health as they don’t mimic human pathology. More than 90% of all drugs fail clinical trials after extensive animal testing due to the fact that animal studies do not reflect human physiology and inter-individual differences.